<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>HIV | Michael Schomaker</title>
    <link>https://MichaelSchomaker.github.io/tags/hiv/</link>
      <atom:link href="https://MichaelSchomaker.github.io/tags/hiv/index.xml" rel="self" type="application/rss+xml" />
    <description>HIV</description>
    <generator>Source Themes Academic (https://sourcethemes.com/academic/)</generator><language>en-us</language><lastBuildDate>Fri, 15 Mar 2024 00:00:00 +0000</lastBuildDate>
    <image>
      <url>https://MichaelSchomaker.github.io/images/icon_hue888863bcf6448bbe1c2d7b1880687e8_12435_512x512_fill_lanczos_center_3.png</url>
      <title>HIV</title>
      <link>https://MichaelSchomaker.github.io/tags/hiv/</link>
    </image>
    
    <item>
      <title>Is Same-Day Antiretroviral Therapy Initiation Beneficial? Methodological Aspects when Comparing Observational and Randomized Studies</title>
      <link>https://MichaelSchomaker.github.io/publication/2023-12-31_is_same_day/</link>
      <pubDate>Fri, 15 Mar 2024 00:00:00 +0000</pubDate>
      <guid>https://MichaelSchomaker.github.io/publication/2023-12-31_is_same_day/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Post-traumatic stress disorder as a risk factor for major adverse cardiovascular events: a cohort study of a South African medical insurance scheme</title>
      <link>https://MichaelSchomaker.github.io/publication/2024_02_05_post_traumatic_stress/</link>
      <pubDate>Mon, 05 Feb 2024 00:00:00 +0000</pubDate>
      <guid>https://MichaelSchomaker.github.io/publication/2024_02_05_post_traumatic_stress/</guid>
      <description></description>
    </item>
    
    <item>
      <title>High Unreported Mortality in Children and Youth (&lt;25 Years) Living With HIV Who Were Lost to Care From Antiretroviral Therapy Programs in Southern Africa: Results From a Multicountry Tracing Study</title>
      <link>https://MichaelSchomaker.github.io/publication/2022-12-15-high_unreported/</link>
      <pubDate>Thu, 15 Dec 2022 00:00:00 +0000</pubDate>
      <guid>https://MichaelSchomaker.github.io/publication/2022-12-15-high_unreported/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Virologic non-suppression and early loss to follow up among pregnant and non-pregnant adolescents aged 15â€“19 years initiating antiretroviral therapy in South Africa: a retrospective cohort study</title>
      <link>https://MichaelSchomaker.github.io/publication/2022-01-15_virologic_nonsuppression/</link>
      <pubDate>Sat, 15 Jan 2022 00:00:00 +0000</pubDate>
      <guid>https://MichaelSchomaker.github.io/publication/2022-01-15_virologic_nonsuppression/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Predicting, Diagnosing, and Treating Acute and Early HIV Infection in a Public Sector Facility in Eswatini</title>
      <link>https://MichaelSchomaker.github.io/publication/2021-12-15_predicting_hiv/</link>
      <pubDate>Wed, 15 Dec 2021 00:00:00 +0000</pubDate>
      <guid>https://MichaelSchomaker.github.io/publication/2021-12-15_predicting_hiv/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The impact of same-day antiretroviral therapy initiation under the WHO Treat-All policy</title>
      <link>https://MichaelSchomaker.github.io/publication/2021-03-01_impact_same_day_art/</link>
      <pubDate>Sun, 16 May 2021 00:00:00 +0000</pubDate>
      <guid>https://MichaelSchomaker.github.io/publication/2021-03-01_impact_same_day_art/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Virologic response of adolescents living with perinatally acquired HIV receiving antiretroviral therapy in the period of early adolescence (10-14 years) in South Africa</title>
      <link>https://MichaelSchomaker.github.io/publication/2021-03-01_virologic_response/</link>
      <pubDate>Thu, 21 Jan 2021 00:00:00 +0000</pubDate>
      <guid>https://MichaelSchomaker.github.io/publication/2021-03-01_virologic_response/</guid>
      <description></description>
    </item>
    
    <item>
      <title>HIV-1 Subtype C Tier 3 Viruses Have Increased Infectivity Compared to Tier 2 Viruses</title>
      <link>https://MichaelSchomaker.github.io/publication/2020-10-01-hiv1_subtype/</link>
      <pubDate>Wed, 25 Nov 2020 00:00:00 +0000</pubDate>
      <guid>https://MichaelSchomaker.github.io/publication/2020-10-01-hiv1_subtype/</guid>
      <description></description>
    </item>
    
    <item>
      <title>HIV programmatic outcomes following implementation of the &#39;Treat-All&#39; policy in a public sector setting in Eswatini: a prospective cohort study</title>
      <link>https://MichaelSchomaker.github.io/publication/2020-01-01_hiv_programmatic_out/</link>
      <pubDate>Tue, 03 Mar 2020 00:00:00 +0000</pubDate>
      <guid>https://MichaelSchomaker.github.io/publication/2020-01-01_hiv_programmatic_out/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Stunting and growth velocity of adolescents with perinatally acquired HIV: differential evolution for males and females. A multiregional analysis from the IeDEA global paediatric collaboration</title>
      <link>https://MichaelSchomaker.github.io/publication/2019-01-01_stunting_and_growth_/</link>
      <pubDate>Fri, 08 Nov 2019 00:00:00 +0000</pubDate>
      <guid>https://MichaelSchomaker.github.io/publication/2019-01-01_stunting_and_growth_/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Feasibility of antiretroviral therapy initiation under the treat-all policy under routine conditions: a prospective cohort study from Eswatini</title>
      <link>https://MichaelSchomaker.github.io/publication/2019-01-01_feasibility_of_antir/</link>
      <pubDate>Thu, 24 Oct 2019 00:00:00 +0000</pubDate>
      <guid>https://MichaelSchomaker.github.io/publication/2019-01-01_feasibility_of_antir/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Decreased risk of HIV-associated TB during antiretroviral therapy expansion in rural Eswatini from 2009 to 2016: a cohort and population-based analysis</title>
      <link>https://MichaelSchomaker.github.io/publication/2019-01-01_decreased_risk_of_hi/</link>
      <pubDate>Sun, 01 Sep 2019 00:00:00 +0000</pubDate>
      <guid>https://MichaelSchomaker.github.io/publication/2019-01-01_decreased_risk_of_hi/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Programmatic outcomes and impact of rapid public sector antiretroviral therapy expansion in adults prior to introduction of the WHO treat-all approach in rural Eswatini</title>
      <link>https://MichaelSchomaker.github.io/publication/2019-01-01_programmatic_outcome/</link>
      <pubDate>Sat, 01 Jun 2019 00:00:00 +0000</pubDate>
      <guid>https://MichaelSchomaker.github.io/publication/2019-01-01_programmatic_outcome/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis</title>
      <link>https://MichaelSchomaker.github.io/publication/2018-01-01_the_epidemiology_of_/</link>
      <pubDate>Thu, 01 Mar 2018 00:00:00 +0000</pubDate>
      <guid>https://MichaelSchomaker.github.io/publication/2018-01-01_the_epidemiology_of_/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Inequality in outcomes for adolescents living with perinatally acquired HIV in sub-Saharan Africa: a Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Cohort Collaboration analysis</title>
      <link>https://MichaelSchomaker.github.io/publication/2018-01-01_inequality_in_outcom/</link>
      <pubDate>Tue, 27 Feb 2018 00:00:00 +0000</pubDate>
      <guid>https://MichaelSchomaker.github.io/publication/2018-01-01_inequality_in_outcom/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Assessing the risk of dolutegravir for women of childbearing potential</title>
      <link>https://MichaelSchomaker.github.io/publication/2018-01-01_assessing_the_risk_o/</link>
      <pubDate>Mon, 01 Jan 2018 00:00:00 +0000</pubDate>
      <guid>https://MichaelSchomaker.github.io/publication/2018-01-01_assessing_the_risk_o/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Contemporary disengagement from antiretroviral therapy in Khayelitsha, South Africa: A cohort study</title>
      <link>https://MichaelSchomaker.github.io/publication/2017-01-01_contemporary_disenga/</link>
      <pubDate>Tue, 07 Nov 2017 00:00:00 +0000</pubDate>
      <guid>https://MichaelSchomaker.github.io/publication/2017-01-01_contemporary_disenga/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Twelve-year mortality in adults initiating antiretroviral therapy in South Africa</title>
      <link>https://MichaelSchomaker.github.io/publication/2017-01-01_twelve-year_mortalit/</link>
      <pubDate>Mon, 25 Sep 2017 00:00:00 +0000</pubDate>
      <guid>https://MichaelSchomaker.github.io/publication/2017-01-01_twelve-year_mortalit/</guid>
      <description></description>
    </item>
    
    <item>
      <title>CD4 count at antiretroviral therapy initiation and the risk of loss to follow-up: results from a multicentre cohort study</title>
      <link>https://MichaelSchomaker.github.io/publication/2016-01-01_cd4_count_at_antiret/</link>
      <pubDate>Fri, 01 Jan 2016 00:00:00 +0000</pubDate>
      <guid>https://MichaelSchomaker.github.io/publication/2016-01-01_cd4_count_at_antiret/</guid>
      <description></description>
    </item>
    
    <item>
      <title>A comparison of death recording by health centres and civil registration in South Africans receiving antiretroviral treatment</title>
      <link>https://MichaelSchomaker.github.io/publication/2015-01-01_a_comparison_of_deat/</link>
      <pubDate>Wed, 16 Dec 2015 00:00:00 +0000</pubDate>
      <guid>https://MichaelSchomaker.github.io/publication/2015-01-01_a_comparison_of_deat/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Superior virologic and treatment outcomes when viral load is measured at 3 months compared to 6 months on antiretroviral therapy</title>
      <link>https://MichaelSchomaker.github.io/publication/2015-01-01_superior_virologic_a/</link>
      <pubDate>Wed, 23 Sep 2015 00:00:00 +0000</pubDate>
      <guid>https://MichaelSchomaker.github.io/publication/2015-01-01_superior_virologic_a/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Anti-V3-Glycan and Anti-MPER Neutralizing Antibodies, but Not Anti-V2-Glycan Site Antibodies, Are Strongly Associated with Greater Anti-HIV-1 Neutralization Breadth and Potency</title>
      <link>https://MichaelSchomaker.github.io/publication/2015-01-01_anti-v3-glycan_and_a/</link>
      <pubDate>Thu, 01 Jan 2015 00:00:00 +0000</pubDate>
      <guid>https://MichaelSchomaker.github.io/publication/2015-01-01_anti-v3-glycan_and_a/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies</title>
      <link>https://MichaelSchomaker.github.io/publication/2014-01-01_mortality_in_patient/</link>
      <pubDate>Tue, 09 Sep 2014 00:00:00 +0000</pubDate>
      <guid>https://MichaelSchomaker.github.io/publication/2014-01-01_mortality_in_patient/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Virologic response in children treated with abacavir-compared with stavudine-based antiretroviral treatment: a South African multi-cohort analysis</title>
      <link>https://MichaelSchomaker.github.io/publication/2014-01-01_virologic_response_i/</link>
      <pubDate>Sun, 01 Jun 2014 00:00:00 +0000</pubDate>
      <guid>https://MichaelSchomaker.github.io/publication/2014-01-01_virologic_response_i/</guid>
      <description></description>
    </item>
    
    <item>
      <title>CD4 count slope and mortality in HIV-infected patients on antiretroviral therapy: multicohort analysis from South Africa</title>
      <link>https://MichaelSchomaker.github.io/publication/2013-01-01_cd4_count_slope_and_/</link>
      <pubDate>Wed, 01 May 2013 00:00:00 +0000</pubDate>
      <guid>https://MichaelSchomaker.github.io/publication/2013-01-01_cd4_count_slope_and_/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Immune recovery after starting ART in HIV-infected patients presenting and not presenting with tuberculosis in South Africa</title>
      <link>https://MichaelSchomaker.github.io/publication/2013-01-01_immune_recovery_afte/</link>
      <pubDate>Wed, 01 May 2013 00:00:00 +0000</pubDate>
      <guid>https://MichaelSchomaker.github.io/publication/2013-01-01_immune_recovery_afte/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies</title>
      <link>https://MichaelSchomaker.github.io/publication/2013-01-01_life_expectancies_of/</link>
      <pubDate>Tue, 09 Apr 2013 00:00:00 +0000</pubDate>
      <guid>https://MichaelSchomaker.github.io/publication/2013-01-01_life_expectancies_of/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Effects of rifampin-based antituberculosis therapy on plasma efavirenz concentrations in children vary by CYP2B6 genotype</title>
      <link>https://MichaelSchomaker.github.io/publication/2013-01-01_effects_of_rifampin-/</link>
      <pubDate>Mon, 04 Mar 2013 00:00:00 +0000</pubDate>
      <guid>https://MichaelSchomaker.github.io/publication/2013-01-01_effects_of_rifampin-/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Effectiveness of patient adherence groups as a model of care for stable patients on antiretroviral therapy in Khayelitsha, Cape Town, South Africa</title>
      <link>https://MichaelSchomaker.github.io/publication/2013-01-01_effectiveness_of_pat/</link>
      <pubDate>Wed, 13 Feb 2013 00:00:00 +0000</pubDate>
      <guid>https://MichaelSchomaker.github.io/publication/2013-01-01_effectiveness_of_pat/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Tuberculosis and the risk of opportunistic infections and cancers in HIV-infected patients starting ART in Southern Africa</title>
      <link>https://MichaelSchomaker.github.io/publication/2013-01-01_tuberculosis_and_the/</link>
      <pubDate>Fri, 01 Feb 2013 00:00:00 +0000</pubDate>
      <guid>https://MichaelSchomaker.github.io/publication/2013-01-01_tuberculosis_and_the/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicentre cohort study</title>
      <link>https://MichaelSchomaker.github.io/publication/2012-01-01_gender_differences_i/</link>
      <pubDate>Tue, 04 Sep 2012 00:00:00 +0000</pubDate>
      <guid>https://MichaelSchomaker.github.io/publication/2012-01-01_gender_differences_i/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Refined identification of neutralization-resistant HIV-1 CRF02_AG viruses</title>
      <link>https://MichaelSchomaker.github.io/publication/2012-01-01_refined_identificati/</link>
      <pubDate>Sun, 01 Jan 2012 00:00:00 +0000</pubDate>
      <guid>https://MichaelSchomaker.github.io/publication/2012-01-01_refined_identificati/</guid>
      <description></description>
    </item>
    
  </channel>
</rss>
